# Efficacy and Safety Study of Calcipotriol Betamethasone Plus Calcipotriol in Sequential Therapy to Psoriasis

> **NCT02191007** · NA · COMPLETED · sponsor: **Xijing Hospital** · enrollment: 230 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Calcipotriol Betamethasone ointment and Calcipotriol ointment
- **DRUG:** Calcipotriol Betamethasone ointment
- **DRUG:** Calcipotriol Betamethasone ointment and Urea Cream

## Key facts

- **NCT ID:** NCT02191007
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2014-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02191007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02191007, "Efficacy and Safety Study of Calcipotriol Betamethasone Plus Calcipotriol in Sequential Therapy to Psoriasis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02191007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*